Search research articles
Contact Us
Filters
Showing results (361-370 of 371) with videos related to
Page
of 38
Sort By:
Applied and Environmental Microbiology
|
May 29, 2007
Ecological genomics of marine Roseobacters
M A Moran, R Belas, M A Schell, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2023
Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life
Kevin J Filipski, David J Edmonds, Michelle R Garnsey, et al.
Journal of Medicinal Chemistry
|
April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists
Huy N Hoang, Kun Song, Timothy A Hill, et al.
Journal of Medicinal Chemistry
|
August 29, 2013
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure
David A Griffith, Robert L Dow, Kim Huard, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed
Timothy A Hill, Rink-Jan Lohman, Huy N Hoang, et al.
Journal of Medicinal Chemistry
|
June 1, 2022
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
David A Griffith, David J Edmonds, Jean-Philippe Fortin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 15, 2017
Selective Activation of AMPK <i>β</i>1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
Christopher T Salatto, Russell A Miller, Kimberly O Cameron, et al.
Journal of Medicinal Chemistry
|
August 5, 2016
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
Kimberly O Cameron, Daniel W Kung, Amit S Kalgutkar, et al.
Journal of Medicinal Chemistry
|
August 19, 2020
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Kim Huard, Aaron C Smith, Gregg Cappon, et al.
Nature Communications
|
January 2, 2025
Design and application of synthetic 17B-HSD13 substrates reveals preserved catalytic activity of protective human variants
Michelle R Garnsey, Yang Wang, David J Edmonds, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 371) with videos related to
Sort By:
Page
of 38
Applied and Environmental Microbiology
|
May 29, 2007
Ecological genomics of marine Roseobacters
M A Moran, R Belas, M A Schell, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2023
Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life
Kevin J Filipski, David J Edmonds, Michelle R Garnsey, et al.
Journal of Medicinal Chemistry
|
April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists
Huy N Hoang, Kun Song, Timothy A Hill, et al.
Journal of Medicinal Chemistry
|
August 29, 2013
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure
David A Griffith, Robert L Dow, Kim Huard, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed
Timothy A Hill, Rink-Jan Lohman, Huy N Hoang, et al.
Journal of Medicinal Chemistry
|
June 1, 2022
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
David A Griffith, David J Edmonds, Jean-Philippe Fortin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 15, 2017
Selective Activation of AMPK <i>β</i>1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
Christopher T Salatto, Russell A Miller, Kimberly O Cameron, et al.
Journal of Medicinal Chemistry
|
August 5, 2016
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
Kimberly O Cameron, Daniel W Kung, Amit S Kalgutkar, et al.
Journal of Medicinal Chemistry
|
August 19, 2020
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Kim Huard, Aaron C Smith, Gregg Cappon, et al.
Nature Communications
|
January 2, 2025
Design and application of synthetic 17B-HSD13 substrates reveals preserved catalytic activity of protective human variants
Michelle R Garnsey, Yang Wang, David J Edmonds, et al.
Page
of 38